Advancing Cancer Care Equity: Yes, and…
Takeda Partnership With Xavier University Seeks Blueprint to Advance Health Equity
NPC Weighs in on PBM Inquiry; Radiologist Receives Award; OneOncology Creates Disease Groups
News from Strategic Alliance Partners of The American Journal of Managed Care®.
Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings
Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care
The Institute for Value-Based Medicine series visits Texas Oncology in Austin.
How Advocacy Groups and Patient Data Can Help Drive Health Equity
Taking Action to Address Health Equity in Oncology
New Enhancing Oncology Model Builds on Knowledge From the OCM
OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services
Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies
A Call to Action: Oncology Practices—and Patients—Need Performance Measures for Managing Oral Therapies
Zelenetz Discusses How to Evaluate Responses to Therapy in DLBCL
Andrew Zelenetz, MD, PhD, medical oncologist at Memorial Sloan Kettering Cancer Center, is the current chair of the Non-Hodgkin Lymphoma Guidelines panel of the National Comprehensive Cancer Network (NCCN).
Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action
No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
Patel et al, Appendix B
Patel et al Appendix A
